FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to dermatology, paediatrics, allergology and immunology, and can be used for prediction of atopic dermatitis in children. That is ensured by determining the concentration of interleukin-22 in blood serum of a child with atopic dermatitis when entering the hospital and with interleukin-22 concentration of 35 pg/ml to 62 pg/ml, mild atopic dermatitis is predicted; at concentration of 63 pg/ml to 90 pg/ml, a moderate degree is predicted, and if concentration is 91 pg/ml and higher, a severe degree of severity of atopic dermatitis.
EFFECT: method enables more accurate prediction of the severity of atopic dermatitis in children.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF SEVERITY OF ATOPIC DERMATITIS IN CHILDREN | 2017 |
|
RU2677481C1 |
| METHOD OF PREDICTING DEGREE OF ATOPIC DERMATITIS IN CHILDREN | 2016 |
|
RU2630063C1 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN ATOPIC DERMATITIS IN PREGNANT WOMEN USING COMBINATION OF EMOLLIENT AND TOPICAL ANTIPRURITIC AGENT | 2024 |
|
RU2828120C1 |
| METHOD FOR PREDICTING SEVERITY OF ATOPIC DERMATITIS IN CHILDREN WITH ACCOMPANYING INTESTINAL DYSBACTERIOSIS | 2018 |
|
RU2692803C1 |
| METHOD FOR PREDICTION OF CHILDREN ATOPIC DERMATITIS RISK | 2019 |
|
RU2703546C1 |
| METHOD FOR DETERMINING THE STAGE OF ATOPIC DERMATITIS | 2021 |
|
RU2772411C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPING ATOPIC DERMATITIS IN CHILDREN IN FIRST FOUR WEEKS OF LIFE | 2024 |
|
RU2828551C1 |
| METHOD FOR PREDICTION OF THE RISK OF DEVELOPMENT OF RECURRENT ATOPIC DERMATITIS | 2022 |
|
RU2794084C1 |
| METHOD OF ATOPIC DERMATITIS PREDICTION IN INFANTS | 2008 |
|
RU2353927C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE AND EVALUATION OF CLINICAL EFFECTIVENESS OF ATOPIC DERMATITIS TREATMENT | 2015 |
|
RU2603463C1 |
